Reviews Vaprisol


No reviews yet.

Vaprisol Drug Description
VAPRISOL®
(conivaptan hydrochloride) Injection, for Intravenous Use
DRUG DESCRIPTION



What are the possible side effects of conivaptan (Vaprisol)?

Tell your doctor or nurse right away if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Tell your doctor or nurse if you have any of these other serious side effects:

pain, redness, or swelling where the IV needle is placed;
irregular heartbeats;
confusion, extreme thirst;
vomiting, diarrhea;
feeling light-headed, fainting;
swelling, rapid weight gain;...
Read All Potential Side Effects for Vaprisol »




Conivaptan hydrochloride is chemically [1,1'-biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-,
monohydrochloride, having a molecular weight of 535.04 and molecular formula
C32H26N4O2•HCl. The structural
formula of conivaptan hydrochloride is:








Conivaptan hydrochloride is a white to off-white or pale orange-white powder
that is very slightly soluble in water (0.15 mg/mL at 23° C). Conivaptan
hydrochloride injection is supplied as a sterile premixed solution with dextrose
in a flexible plastic container.
Each container contains a clear, colorless, sterile, non-pyrogenic solution
of conivaptan hydrochloride in dextrose. Each 100 mL, single-use premixed INTRAVIA
Container contains 20 mg of conivaptan hydrochloride and 5 g of Dextrose Hydrous,
USP. Lactic Acid, USP is added for pH adjustment to pH 3.4 to 3.8. The flexible
plastic container is fabricated from a specially designed multilayer plastic
(PL 2408). Solutions in contact with the plastic container leach out certain
of the chemical components from the plastic in very small amounts; however,
biological testing was supportive of the safety of the plastic container materials.
The flexible container has a foil overwrap. Water can permeate the plastic into
the overwrap, but the amount is insufficient to significantly affect the premixed
solution.
Last reviewed on RxList: 6/28/2010




Vaprisol Drug Description
VAPRISOL®
(conivaptan hydrochloride) Injection, for Intravenous Use
DRUG DESCRIPTION



What are the possible side effects of conivaptan (Vaprisol)?

Tell your doctor or nurse right away if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Tell your doctor or nurse if you have any of these other serious side effects:

pain, redness, or swelling where the IV needle is placed;
irregular heartbeats;
confusion, extreme thirst;
vomiting, diarrhea;
feeling light-headed, fainting;
swelling, rapid weight gain;...
Read All Potential Side Effects for Vaprisol »




Conivaptan hydrochloride is chemically [1,1'-biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-,
monohydrochloride, having a molecular weight of 535.04 and molecular formula
C32H26N4O2•HCl. The structural
formula of conivaptan hydrochloride is:








Conivaptan hydrochloride is a white to off-white or pale orange-white powder
that is very slightly soluble in water (0.15 mg/mL at 23° C). Conivaptan
hydrochloride injection is supplied as a sterile premixed solution with dextrose
in a flexible plastic container.
Each container contains a clear, colorless, sterile, non-pyrogenic solution
of conivaptan hydrochloride in dextrose. Each 100 mL, single-use premixed INTRAVIA
Container contains 20 mg of conivaptan hydrochloride and 5 g of Dextrose Hydrous,
USP. Lactic Acid, USP is added for pH adjustment to pH 3.4 to 3.8. The flexible
plastic container is fabricated from a specially designed multilayer plastic
(PL 2408). Solutions in contact with the plastic container leach out certain
of the chemical components from the plastic in very small amounts; however,
biological testing was supportive of the safety of the plastic container materials.
The flexible container has a foil overwrap. Water can permeate the plastic into
the overwrap, but the amount is insufficient to significantly affect the premixed
solution.
Last reviewed on RxList: 6/28/2010




Vaprisol Drug Description
VAPRISOL®
(conivaptan hydrochloride) Injection, for Intravenous Use
DRUG DESCRIPTION



What are the possible side effects of conivaptan (Vaprisol)?

Tell your doctor or nurse right away if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Tell your doctor or nurse if you have any of these other serious side effects:

pain, redness, or swelling where the IV needle is placed;
irregular heartbeats;
confusion, extreme thirst;
vomiting, diarrhea;
feeling light-headed, fainting;
swelling, rapid weight gain;...
Read All Potential Side Effects for Vaprisol »




Conivaptan hydrochloride is chemically [1,1'-biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-,
monohydrochloride, having a molecular weight of 535.04 and molecular formula
C32H26N4O2•HCl. The structural
formula of conivaptan hydrochloride is:








Conivaptan hydrochloride is a white to off-white or pale orange-white powder
that is very slightly soluble in water (0.15 mg/mL at 23° C). Conivaptan
hydrochloride injection is supplied as a sterile premixed solution with dextrose
in a flexible plastic container.
Each container contains a clear, colorless, sterile, non-pyrogenic solution
of conivaptan hydrochloride in dextrose. Each 100 mL, single-use premixed INTRAVIA
Container contains 20 mg of conivaptan hydrochloride and 5 g of Dextrose Hydrous,
USP. Lactic Acid, USP is added for pH adjustment to pH 3.4 to 3.8. The flexible
plastic container is fabricated from a specially designed multilayer plastic
(PL 2408). Solutions in contact with the plastic container leach out certain
of the chemical components from the plastic in very small amounts; however,
biological testing was supportive of the safety of the plastic container materials.
The flexible container has a foil overwrap. Water can permeate the plastic into
the overwrap, but the amount is insufficient to significantly affect the premixed
solution.
Last reviewed on RxList: 6/28/2010




Vaprisol Drug Description
VAPRISOL®
(conivaptan hydrochloride) Injection, for Intravenous Use
DRUG DESCRIPTION



What are the possible side effects of conivaptan (Vaprisol)?

Tell your doctor or nurse right away if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Tell your doctor or nurse if you have any of these other serious side effects:

pain, redness, or swelling where the IV needle is placed;
irregular heartbeats;
confusion, extreme thirst;
vomiting, diarrhea;
feeling light-headed, fainting;
swelling, rapid weight gain;...
Read All Potential Side Effects for Vaprisol »




Conivaptan hydrochloride is chemically [1,1'-biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-,
monohydrochloride, having a molecular weight of 535.04 and molecular formula
C32H26N4O2•HCl. The structural
formula of conivaptan hydrochloride is:








Conivaptan hydrochloride is a white to off-white or pale orange-white powder
that is very slightly soluble in water (0.15 mg/mL at 23° C). Conivaptan
hydrochloride injection is supplied as a sterile premixed solution with dextrose
in a flexible plastic container.
Each container contains a clear, colorless, sterile, non-pyrogenic solution
of conivaptan hydrochloride in dextrose. Each 100 mL, single-use premixed INTRAVIA
Container contains 20 mg of conivaptan hydrochloride and 5 g of Dextrose Hydrous,
USP. Lactic Acid, USP is added for pH adjustment to pH 3.4 to 3.8. The flexible
plastic container is fabricated from a specially designed multilayer plastic
(PL 2408). Solutions in contact with the plastic container leach out certain
of the chemical components from the plastic in very small amounts; however,
biological testing was supportive of the safety of the plastic container materials.
The flexible container has a foil overwrap. Water can permeate the plastic into
the overwrap, but the amount is insufficient to significantly affect the premixed
solution.
Last reviewed on RxList: 6/28/2010




Vaprisol Drug Description
VAPRISOL®
(conivaptan hydrochloride) Injection, for Intravenous Use
DRUG DESCRIPTION



What are the possible side effects of conivaptan (Vaprisol)?

Tell your doctor or nurse right away if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Tell your doctor or nurse if you have any of these other serious side effects:

pain, redness, or swelling where the IV needle is placed;
irregular heartbeats;
confusion, extreme thirst;
vomiting, diarrhea;
feeling light-headed, fainting;
swelling, rapid weight gain;...
Read All Potential Side Effects for Vaprisol »




Conivaptan hydrochloride is chemically [1,1'-biphenyl]-2-carboxamide, N-[4-[(4,5-dihydro-2methylimidazo[4,5-d][1]benzazepin-6(1H)-yl)carbonyl]phenyl]-,
monohydrochloride, having a molecular weight of 535.04 and molecular formula
C32H26N4O2•HCl. The structural
formula of conivaptan hydrochloride is:








Conivaptan hydrochloride is a white to off-white or pale orange-white powder
that is very slightly soluble in water (0.15 mg/mL at 23° C). Conivaptan
hydrochloride injection is supplied as a sterile premixed solution with dextrose
in a flexible plastic container.
Each container contains a clear, colorless, sterile, non-pyrogenic solution
of conivaptan hydrochloride in dextrose. Each 100 mL, single-use premixed INTRAVIA
Container contains 20 mg of conivaptan hydrochloride and 5 g of Dextrose Hydrous,
USP. Lactic Acid, USP is added for pH adjustment to pH 3.4 to 3.8. The flexible
plastic container is fabricated from a specially designed multilayer plastic
(PL 2408). Solutions in contact with the plastic container leach out certain
of the chemical components from the plastic in very small amounts; however,
biological testing was supportive of the safety of the plastic container materials.
The flexible container has a foil overwrap. Water can permeate the plastic into
the overwrap, but the amount is insufficient to significantly affect the premixed
solution.
Last reviewed on RxList: 6/28/2010





Other reviews about Vaprisol on wordpress

2005 Drug Approvals
  by Mike
New molecular entities and new biologicals, 2005a Abatacept for i.v. infusion, (Orencia, Bristol-Myers Squibb), for the second-line treatment of adults with moderately to severely active rheumatoid arthritis. Conivaptan hydrochloride injection […]


Drugs Approved by the FDA (2005)
  by Karthikram
Drugs which got approval from FDA for the year 2005. Happy to see more than a dozen drugs..Hope to see more than 30 this year..New technologies will be […]


Vaprisol (Conivaptan) -- a Treatment for Hyponatremia (Low Blood Sodium)
  by heremias
Vaprisol is a newly released drug treatment for low sodium in the blood (also called "hyponatremia").First, some background. Hyponatremia is a medical condition that can have many possible […]


Monthly Introduction to Tech Medicine
  by heremias
What's this blog all about?My goal in Tech Medicine will be to explore the intersection of medicine, new technologies, and the Internet. This is a purposefully broad topic. […]


Schering's Levitra, Others, May Lead to Dangerous Side Effects if Combined With Any of 56 Common Medicines, Consumer Advocates Say. . . .
  by condor
Bloomberg is pushing a story, tonight, that highlights the serious side-effect risks associated with the entire currently-approved class of so-called "erectile dysfunction" drugs: they shouldn't be taken with […]


FDA MedWatch - May 2010 Drug Safety Labeling Changes
  by irbtipoftheweek
The MedWatch May 2010 Drug Safety Labeling Changes posting includes 23 products with safety labeling changes to the following sections: BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, PATIENT […]



Other reviews about Vaprisol on web:

Astellas Leading Light for Life Vaprisol.com


Vaprisol information from Drugs.com, includes Vaprisol side effects, interactions and indications. Vaprisol Information from Drugs.com


Learn about the prescription medication Vaprisol (Conivaptan Hcl Injection), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Vaprisol (Conivaptan Hcl Injection) Drug Information: Uses, Side ...


Accurate, FDA approved Vaprisol information for healthcare professionals and patients - brought to you by Drugs.com. Vaprisol Official FDA information, side effects and uses.


Visit the Vaprisol ® Web site for more information about this medication. View Vaprisol ® U.S. Physician Prescribing Information. Astellas Pharma US, Inc. | Vaprisol


Drug information and side-effects for Vaprisol (conivaptan) Vaprisol (conivaptan) - Drug information from MediLexicon


Request More Information. You can stay up-to-date with the latest information about Vaprisol by registering here. Vaprisol: Registration


Learn about Vaprisol from the publishers of the Physicians Desk Reference. Find prescription drug information resources including interactions, side effects, symptoms ... Vaprisol | Prescription Drug Information, Side Effects | PDRHealth


1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use VAPRISOL safely and effectively. See full prescribing information for VAPRISOL HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not ...


Consumer information and patient comments on perscription drugs ... We currently have info on 350 drugs Users have posted 4369 comments Vaprisol - The Internet Drug Database





Featured Reviews

Reviews Infanrix

Infanrix Drug Description INFANRIX® Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed DRUG DESCRIPTION What are the possible side effects of diphtheria, tetanus, acellular pertussis vaccine (Daptacel (DTaP),...
Read More  |  Review This
Reviews Fluorouracil Topical Cream

Fluoroplex Drug Description FLUOROPLEX® (fluorouracil) 1% Topical Cream DRUG DESCRIPTION What are the possible side effects of fluorouracil topical (Carac, Efudex, Fluoroplex)? Serious side effects are not likely to occur....
Read More  |  Review This
Reviews Neupro

Neupro Drug Description Neupro® (rotigotine transdermal system) CONTINUOUS DELIVERY FOR ONCE-DAILY APPLICATION DRUG DESCRIPTION What are the possible side effects of rotigotine (Neupro)? Get emergency medical help if you have...
Read More  |  Review This
Reviews Flavoxate HCl

Urispas Drug Description DRUG DESCRIPTION What are the possible side effects of flavoxate (Urispas)? Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....